Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HyperVue™ Imaging System

K-Number: K230691 · 2023-06-07

Decision Date2023-06-07
Product CodeNQQ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

HyperVue™ Imaging System is a medical device manufactured by Spectrawave, Inc.. It received FDA 510(k) clearance on 2023-06-07 under approval number K230691. The device is classified under product code NQQ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HyperVue™ Imaging System?

HyperVue™ Imaging System is a medical device that received FDA 510(k) clearance on 2023-06-07. It is manufactured by Spectrawave, Inc.. The 510(k) number is K230691.

When was HyperVue™ Imaging System approved by the FDA?

HyperVue™ Imaging System received FDA 510(k) clearance on 2023-06-07, under approval number K230691.

What company makes HyperVue™ Imaging System?

HyperVue™ Imaging System is manufactured by Spectrawave, Inc..

What is the FDA product code for HyperVue™ Imaging System?

The FDA product code for HyperVue™ Imaging System is NQQ.

Related Clinical Trials

Related PubMed Literature

Other Devices by Spectrawave, Inc.

Related Devices (Code: NQQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.